Owlstone Medical

To add a bio or update company history, please click update information.

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

6 Oct 2025

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

Owlstone Medical develops breath-based diagnostic technologies that detect disease using chemical markers, enabling non-invasive screening and monitoring for cancer and chronic conditions at home or point of care.

Owlstone Medical

Life Sciences
Cambridge, United Kingdom
£36m
owlstonemedical.com
Update Information

More venture news

BIOCAPTIVA
9 Mar 2026
BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
EquityLife Sciences
LifeCellsNI
4 Mar 2026
LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility
Pre-seedLife Sciences
3 Mar 2026
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Series ALife Sciences

Owlstone Medical

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

More venture news

BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy

LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility

Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases